EFX vs EXOZ · P/E 54, rev $5.68B vs rev $70.1K
Equifax Inc (EFX) versus eXoZymes, Inc. (EXOZ) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
eXoZymes, Inc. (EXOZ) is a biotechnology company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported EXOZ revenue for 2023-12-31 was $70.1K. Net income was -$2.0M. Revenue was down 1.0% from 2023-09-30 to 2023-12-31. EXOZ currently screens at market cap $83.5M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. EXOZ currently screens at market cap $83.5M.
Not investment advice. Open the EFX and EXOZ stock pages for the full models.
Not investment advice.